Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multi-Drug Resistant Gram-Negative Infections

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00603-19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Multi-Drug–Resistant Gram-Negative Infections in Deployment-Related Trauma Patients

Surgical Infections
SurgeryInfectious DiseasesMicrobiology
2017English

In Vitro Effect of Fosfomycin on Multi-Drug Resistant Gram-Negative Bacteria Causing Urinary Tract Infections

Infection and Drug Resistance
Infectious DiseasesPharmacology
2019English

Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter Baumannii Infections

Drugs
Pharmacology
2014English

Epidemiology of Multi Drug Resistant Gram Negative Bacteria in Kathmandu, Nepal

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Antibacterial Activity of Nineteen Selected Natural Products Against Multi-Drug Resistant Gram-Negative Phenotypes

SpringerPlus
Multidisciplinary
2015English

Antimicrobial Therapy for Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria

The Korean Journal of Medicine
2018English

Pin45 - Cost-Effectiveness of Ceftazidime/Avibactam for the Treatment of Infections Due to Aerobic Gram-Negative Organisms in Patients With Limited Treatment Options

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Treatment of Complicated Intra-Abdominal Infections in the Era of Multi-Drug Resistant Bacteria

European Journal of Medical Research
Medicine
2010English

In Vitro Activity of Tebipenem (SPR859) Against Penicillin-Binding Proteins of Gram-Negative and Gram-Positive Bacteria

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy